Guarantees of National Safety
Russian Pharma manufacturers are willing to launch full-scale production of all vaccines in the National Vaccination Calendar.
Pharmaceutical companies and research teams involved in development and manufacture of vaccines were involved in round table discussions with representatives of the Ministry of Industry and Trade of the Russian Federation on the issues of export of Russian drugs to CIS markets and potential public-business interaction in the field of immunoprophylaxis.
Much attention was paid to development of export potential of Russian vaccines, international cooperation and partnership in that area. Representatives of the companies discussed the access achieved, analyzed issues that suppliers face at the international Pharma market.
Olga Kolotilova, Director of Pharmaceutical and Healthcare Industry Development Department accentuated the issue on the need to organize local full cycle production of multicomponent vaccines, as it ensures national safety.
Olga Kolotilova reported that the Ministry of Health has already prepared and submitted to the Government a list of immunobiological drugs that the Ministry considers important to be manufactured locally.
That idea was extended by Kirill Mizerov, deputy general director for strategic development of Nacimbio, who marked particular importance of import substitution in development of multicomponent vaccines and real full cycle manufacture. Talking about biological safety, he told about market launch of a new Pentavaccine, with full cycle local manufacture.